HAVCR2 and cancer: Another important aspect of PD-1+Tim-3+ is that it provides a new perspective in immunotherapy (for the design of targeted therapies) and tumor progression, establishing the response to the interaction between cancer and immune cells, and guiding prognosis in patients.